Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Significant Accounting Policies [Line Items]
Allowance for doubtful accounts receivable	$ 0		$ 0		$ 0
Bad debt expense	0	$ 0	0	$ 0
Deferred offering costs	$ 115,488		$ 115,488		241,637
Shares of common stock underlying pre-funded warrants	3,106,100		3,106,100
Shelf Registration Statement [Member]
Significant Accounting Policies [Line Items]
Deferred offering costs	$ 115,000		$ 115,000
Public Offering [Member]
Significant Accounting Policies [Line Items]
Deferred offering costs					242,000
Accounts Payable and Accrued Expenses [Member]
Significant Accounting Policies [Line Items]
Liabilities for co-pay assistance	$ 160,000		160,000		66,000
Accounts Receivable [Member]
Significant Accounting Policies [Line Items]
Medicaid and Medicare rebates			$ 130,000		$ 46,000
Pre-Funded Warrants [Member]
Significant Accounting Policies [Line Items]
Shares of common stock underlying pre-funded warrants	580,610		580,610
Pre-Funded Warrants, Modified Series A Warrants and Modified Series C Warrants [Member]
Significant Accounting Policies [Line Items]
Shares of common stock underlying pre-funded warrants	1,204,413		1,204,413